ADIL
ADIL
Last
$3.90
Day
-1.8%
1y
-62.1%
5y
-99.8%
52w
-63.1%
SPY YTD
+13.3%
Sec
—
Earnings
2026-11-1233d
EMA 21
4.41
EMA 50
4.44
EMA 200
4.88
20d high
-26.2%
5y high
-99.9%
5y range
0th
Positions held
Your positionsADIL isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-24
Hold
avoid
Signal
Strong Sell
Target
$4.71
Stop
$3.35
Stop distance
14.1%
Target vs last
+20.8%
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-30 · Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
2026-08-25 · Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
2026-08-17 · Adial Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update
Price (daily)
Full chart · RSI · MACD · patternsADIL · daily-9.8% over 14 sessions
Close EMA21 EMA50 EMA200